American Association of Diabetes Educators.Prevention of transmission of blood-borne infectious agents during blood glucose monitoring [Position Statement]. Diabetes Educ1988; 14:425-26.
2.
Centers for Disease Control.Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood-borne pathogens in health care setting . MMWR1988;37:377-82.
3.
Grandy G., Lee U., Prince A., et al. Hepatitis B immunoglobulin for accidental exposure among medical personnel. J Infect Dis1978;138:625-38..
4.
Seef L., Wright E., Zimmerman H., et al. Type B hepatitis after needlestick exposure and prevention with hepatitis B immunoglobulin. Ann Int Med1978 ;88:285-93.
5.
Centers for Disease Control.Recommendations for prevention of HIV transmission in health care settings , MMWR1987;36:2S-18S.
6.
Scott M., Scott M Jr. HIV infection associated with injections of anabolic steroids . JAMA1989; 262: 207-8.
7.
Doll D.Tattooing in prison and HIV infection. Lancet1988;1:66-67.
8.
Vitlecog D., Mettetal J., Rouzioux C., et al. Acute HIV infection after acupuncture treatments. N Engl J Med1989;320:250-51.
9.
Douvin C., Simon D., Zinelabidine H.An outbreak of hepatitis B in an endocrinology unit traced to a capillary blood-sampling device [Correspondence]. N Engl J Med1990;322:57.
10.
Bauer F., Klotz P., Ginier P., et al. Nosocomial transmission of hepatitis B virus associated with a spring-loaded fingerstick device—California. MMWR1990;39:610-12.
11.
Hepatitis B transmission via spring-loaded devices. FDA Safety Alert 1990 Aug 28.
12.
Shalit P., Brennan C., Murphy V., et al. Risk of cross-infection through shared diabetes devices [Letter] . JAMA1990;263:34-35.
